Central serous chorioretinopathy and steroid-induced cataract caused by glucocorticoid therapy for a civil aviation pilot with chronic nephritis and literature review
10.3760/cma.j.cn113854-20231124-00093
- VernacularTitle:民航飞行员慢性肾炎糖皮质激素治疗后诱发中心性浆液性脉络膜视网膜病变及激素性白内障1例并文献复习
- Author:
Yahui ZHANG
1
;
Xiaoming ZENG
1
;
Jing XU
1
;
Changliang MENG
1
;
Yihong OU
1
Author Information
1. 中国南方航空股份有限公司航空卫生中心，广州 510405
- Publication Type:Journal Article
- Keywords:
Glucocorticoid;
Central serous chorioretinopathy;
Eligibility determination;
Glucocorticoid induced cataract;
Civil pilot
- From:
Chinese Journal of Aerospace Medicine
2024;35(3):223-226
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To provide basis for civil aviation medical appraisal and aviation health support work by analyzing the classic case of ophthalmic suspension in civil aviation pilots and summarizing the experience.Methods:A grounding case of civil aviation pilot, who was developed central serous chorioretinopathy (CSC) and glucocorticoid induced cataract (GIC) after glucocorticoid (GC) treatment for chronic nephritis, was retrospective analyzed and the relevant literatures were reviewed.Results:The patient, a 36-year-old male pilot of a B737 airline fleet, was diagnosed with chronic glomerulonephritis on November 8, 2020. He was treated with GC, cyclophosphamide, cyclosporine, and other medications. In March 2021, he was diagnosed with bilateral CSC and bilateral GIC after ophthalmology consultation due to his continually decreased binocular vision. The patient was treated with local retinal photocoagulation in both eyes and phacoemulsification and intraocular lens implantation for cataract in the right eye. After treatment, there was no improvement in the visual function of the right eye, and the visual function did not meet the corresponding medical standards of the medical examination certificate, resulting in he was unqualified for flight.Conclusions:Civil aviation pilots should pay attention to the possible adverse reactions that may be caused by the use of GC in the eyes. It is necessary to use GC scientifically and reasonably, and actively treat the induced CSC and GIC. Aviation physicians should strengthen health guidance, intervention, and tracking management for the pilots suffering from the above-mentioned eye diseases, and do a good job in promoting their health management.
